Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yu Gao, Andrew N. Shelling, David Porter, Euphemia Leung & Zimei Wu. (2023) Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis. Pharmaceutical Development and Technology 28:3-4, pages 288-298.
Read now
Read now
Roshan Katekar, Pragati Singh, Richa Garg, Saurabh Verma & Jiaur R. Gayen. (2022) Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers. Pharmaceutical Development and Technology 27:1, pages 95-107.
Read now
Read now
Rujing Chen, Shuting Ni, Wangyan Chen, Mei Liu, Jianfang Feng & Kaili Hu. (2021) Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles. International Journal of Nanomedicine 16, pages 5265-5279.
Read now
Read now
Qi-Zhu Feng, Xian-Zhi Chen, Jie Sun, Man-Man Lu, Yong Wang, Qi Wang & Chao Zhang. (2021) Analysis of the Effect of Trastuzumab Combined with Docetaxel on Serum Tumor Markers in the Treatment of HER-2 Positive Breast Cancer and Factors Influencing Therapeutic Efficacy. Cancer Management and Research 13, pages 8077-8084.
Read now
Read now
Fengyong Wang, Yuanshui Sun & Jianfeng Shi. (2019) Programmed Death-Ligand 1 Monoclonal Antibody-Linked Immunoliposomes for Synergistic Efficacy of miR-130a and Oxaliplatin in Gastric Cancers. Nanomedicine 14:13, pages 1729-1744.
Read now
Read now
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, Manon Carré, Bertrand Pourroy, Fanny Bouquet, Ariel Savina, Bruno Lacarelle, Joseph Ciccolini & Raphaelle Fanciullino. (2018) From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer. International Journal of Nanomedicine 13, pages 6677-6688.
Read now
Read now
Articles from other publishers (31)
Mathilde Dacos, Benoît Immordino, Erwan Diroff, Guillaume Sicard, Artemis Kosta, Anne Rodallec, Sarah Giacometti, Joseph Ciccolini & Raphaëlle Fanciullino. (2024) Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models. International Journal of Pharmaceutics 656, pages 124091.
Crossref
Crossref
Yuyang Zuo, Rujie Sun, Nuala Del Piccolo & Molly M. Stevens. (2024) Microneedle-mediated nanomedicine to enhance therapeutic and diagnostic efficacy. Nano Convergence 11:1.
Crossref
Crossref
Vijay Kumar Panthi, Saroj Bashyal & Keshav Raj Paudel. (2024) Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives. Journal of Drug Delivery Science and Technology 92, pages 105314.
Crossref
Crossref
Afruja Ahad, Fatima Aftab, Alexa Michel, Jason S. Lewis & Maria Contel. (2024) Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers. RSC Medicinal Chemistry 15:1, pages 139-150.
Crossref
Crossref
Bharathi Karunakaran, Raghav Gupta, Pranav Patel, Sagar Salave, Amit Sharma, Dhruv Desai, Derajram Benival & Nagavendra Kommineni. (2023) Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications. Vaccines 11:3, pages 661.
Crossref
Crossref
Bruno Rodrigues Arruda, Maria Gabriela Araújo Mendes, Paulo George Cavalcante de Freitas, Alice Vitoria Frota Reis, Thayane Soares Lima, Luiziana Cavalcante Costa Fernandes Crisóstomo, Karina Alexandre Barros Nogueira, Cláudia Pessoa, Raquel Petrilli & Josimar O. Eloy. (2023) Nanocarriers for delivery of taxanes: A review on physicochemical and biological aspects. Journal of Drug Delivery Science and Technology 80, pages 104070.
Crossref
Crossref
Neha Parveen, Mohammed A.S. Abourehab, Rahul Shukla, Punniyakoti Veeraveedu Thanikachalam, Gaurav Kumar Jain & Prashant Kesharwani. (2023) Immunoliposomes as an emerging nanocarrier for breast cancer therapy. European Polymer Journal 184, pages 111781.
Crossref
Crossref
Aliesha Moudgil, Rajesh Salve, Virendra Gajbhiye & Bhushan P. Chaudhari. (2023) Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum. Chemistry and Physics of Lipids 250, pages 105258.
Crossref
Crossref
João Vito Barroso de Freitas, Alice Vitoria Frota Reis, Alan Denis Olivindo Silva, Ana Carolina Cruz de Sousa, Jéssica Roberta Pereira Martins, Karina Alexandre Barros Nogueira, Thais da Silva Moreira, Raquel Petrilli & Josimar O. Eloy. 2023. Cancer Nanotechnology. Cancer Nanotechnology
115
176
.
Raghavendra C. Mundargi, Neetika Taneja, Jayeshkumar J. Hadia & Ajay J. Khopade. 2022. Targeted Drug Delivery. Targeted Drug Delivery
69
125
.
Giuseppina Ioele, Martina Chieffallo, Maria Antonietta Occhiuzzi, Michele De Luca, Antonio Garofalo, Gaetano Ragno & Fedora Grande. (2022) Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties. Molecules 27:17, pages 5436.
Crossref
Crossref
Magdalena Jurczyk, Janusz Kasperczyk, Dorota Wrześniok, Artur Beberok & Katarzyna Jelonek. (2022) Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy. Biomedicines 10:5, pages 1187.
Crossref
Crossref
Sergio Rosales-Mendoza, Alejandra Wong-Arce & Maria de Lourdes Betancourt-Mendiola. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19
129
152
.
A.I. Fraguas-Sanchez, C. Martin-Sabroso, A. Fernandez-Carballido & A.I. Torres-Suarez. 2022. Targeted Nanomedicine for Breast Cancer Therapy. Targeted Nanomedicine for Breast Cancer Therapy
65
110
.
Tianqi Wang, Yusuke Suita, Saradha Miriyala, Jordan Dean, Nikos Tapinos & Jie Shen. (2021) Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy. Pharmaceutics 13:4, pages 520.
Crossref
Crossref
Shashank Chaturvedi & Kamla Pathak. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
299
318
.
Kanokwan Sansanaphongpricha, Paweena Dana, Teerapong Yata & Nattika Saengkrit. 2021. Handbook of Nanotechnology Applications. Handbook of Nanotechnology Applications
537
566
.
Guillaume Sicard, Clément Paris, Sarah Giacometti, Anne Rodallec, Joseph Ciccolini, Palma Rocchi & Raphaëlle Fanciullino. (2020) Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer. Pharmaceutics 12:12, pages 1166.
Crossref
Crossref
Josimar O. Eloy, Amalia Ruiz, Felipe Tita de Lima, Raquel Petrilli, Giovanni Raspantini, Karina Alexandre Barros Nogueira, Elias Santos, Carlos Sabino de Oliveira, Júlio César Borges, Juliana Maldonado Marchetti, Wafa T. Al-Jamal & Marlus Chorilli. (2020) EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. Colloids and Surfaces B: Biointerfaces 194, pages 111185.
Crossref
Crossref
Minh Thanh Vu, Dinh Tien Dung Nguyen, Ngoc Hoi Nguyen, Van Thu Le, The Nam Dao, Thi Huong Nguyen, Tien Dung Cong, Truc Le-Buu Pham, Tri Duc Lam & Ngoc Thuy Trang Le. (2020) Development, Characterization and In Vitro Evaluation of Paclitaxel and Anastrozole Co-Loaded Liposome. Processes 8:9, pages 1110.
Crossref
Crossref
Alberto Juan, Francisco J. Cimas, Iván Bravo, Atanasio Pandiella, Alberto Ocaña & Carlos Alonso-Moreno. (2020) Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment. International Journal of Molecular Sciences 21:17, pages 6018.
Crossref
Crossref
Anne Rodallec, Guillaume Sicard, Sarah Giacometti, Manon Carre, Thomas Maia, Margaux Valette, Fanny Bouquet, Ariel Savina, Bruno Lacarelle, Joseph Ciccolini & Raphaelle Fanciullino. (2020) Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3). Anti-Cancer Drugs 31:5, pages 463-472.
Crossref
Crossref
Mohamed Dawoud, Mohammed A.S. Abourehab & Randa Abdou. (2020) Monoolein cubic nanoparticles as novel carriers for docetaxel. Journal of Drug Delivery Science and Technology 56, pages 101501.
Crossref
Crossref
A. Rodallec, C. Franco, S. Robert, G. Sicard, S. Giacometti, B. Lacarelle, F. Bouquet, A. Savina, R. Lacroix, F. Dignat-George, J. Ciccolini, P. Poncelet & R. Fanciullino. (2020) Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles. Scientific Reports 10:1.
Crossref
Crossref
Na Re Ko, Se Young Van, Sung Hwa Hong, Seog-Young Kim, Miran Kim, Jae Seo Lee, Sang Ju Lee, Yong-kyu Lee, Il Keun Kwon & Seung Jun Oh. (2020) Dual pH- and GSH-Responsive Degradable PEGylated Graphene Quantum Dot-Based Nanoparticles for Enhanced HER2-Positive Breast Cancer Therapy. Nanomaterials 10:1, pages 91.
Crossref
Crossref
Azam Akbari, Azim Akbarzadeh, Morteza Rafiee TehraniReza Ahangari Cohan, Mohsen ChianiMohammad Reza Mehrabi. (2019) Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells. Advanced Pharmaceutical Bulletin 10:1, pages 39-45.
Crossref
Crossref
Zhong Zheng, Haotian Ji, Wenbo Zong, Qiuju Ran, Xinxin Wang, Xi Yang, Zhuo Zhao, Chengjun Yang & Yechen Xiao. (2019) Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3. AMB Express 9:1.
Crossref
Crossref
Cristina Mihaela Ghiciuc, Loredana Beatrice Ungureanu, Raluca Stefania Stanescu & Raoul Vasile Lupusoru. (2019) Nanoparticles in the Therapy of Breast Cancer. Nanoparticles in the Therapy of Breast Cancer.
Jiahui Peng, Juan Chen, Fang Xie, Wei Bao, Hongyan Xu, Hongxia Wang, Yuhong Xu & Zixiu Du. (2019) Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer. Biomaterials 222, pages 119420.
Crossref
Crossref
Monika Marcinkowska, Maciej Stanczyk, Anna Janaszewska, Ewelina Sobierajska, Arkadiusz Chworos & Barbara Klajnert-Maculewicz. (2019) Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy. Pharmaceutical Research 36:11.
Crossref
Crossref
Mingyuan Li, Chunyang Du, Na Guo, Yuou Teng, Xin Meng, Hua Sun, Shuangshuang Li, Peng Yu & Hervé Galons. (2019) Composition design and medical application of liposomes. European Journal of Medicinal Chemistry 164, pages 640-653.
Crossref
Crossref